TREX Trademark

Trademark Overview

On Tuesday, April 12, 2022, a trademark application was filed for TREX with the United States Patent and Trademark Office. The USPTO has given the TREX trademark a serial number of 97358197. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, September 11, 2024. This trademark is owned by Glaukos Corporation. The TREX trademark is filed in the Medical Instrument Products category with the following description:

Surgical implants comprising intraocular ophthalmic synthetic implants, namely, micro-stents, for use in the treatment of diseases of the eye
trex

General Information

Serial Number97358197
Word MarkTREX
Filing DateTuesday, April 12, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, September 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 14, 2023

Trademark Statements

Goods and ServicesSurgical implants comprising intraocular ophthalmic synthetic implants, namely, micro-stents, for use in the treatment of diseases of the eye

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, April 18, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaukos Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92672
Party NameGlaukos Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92672

Trademark Events

Event DateEvent Description
Friday, April 15, 2022NEW APPLICATION ENTERED
Monday, April 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 5, 2023ASSIGNED TO EXAMINER
Friday, January 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 18, 2023SOU EXTENSION 1 FILED
Monday, September 18, 2023SOU EXTENSION 1 GRANTED
Friday, February 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024SOU EXTENSION 3 GRANTED
Wednesday, September 11, 2024SOU EXTENSION 3 FILED
Thursday, April 4, 2024SOU EXTENSION 2 FILED
Thursday, April 4, 2024SOU EXTENSION 2 GRANTED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

trex implants micro stents diseases namely treatment synthetic comprising intraocular ophthalmic